Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 21;23(15):2651-2659.
doi: 10.3748/wjg.v23.i15.2651.

Hepatitis B virus infection and alcohol consumption

Affiliations
Review

Hepatitis B virus infection and alcohol consumption

Ayako Iida-Ueno et al. World J Gastroenterol. .

Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and the second most common cause of cancer deaths worldwide. The top three causes of HCC are hepatitis B virus (HBV), hepatitis C virus (HCV), and alcoholic liver disease. Owing to recent advances in direct-acting antiviral agents, HCV can now be eradicated in almost all patients. HBV infection and alcoholic liver disease are expected, therefore, to become the leading causes of HCC in the future. However, the association between alcohol consumption and chronic hepatitis B in the progression of liver disease is less well understood than with chronic hepatitis C. The mechanisms underlying the complex interaction between HBV and alcohol are not fully understood, and enhanced viral replication, increased oxidative stress and a weakened immune response could each play an important role in the development of HCC. It remains controversial whether HBV and alcohol synergistically increase the incidence of HCC. Herein, we review the currently available literature regarding the interaction of HBV infection and alcohol consumption on disease progression.

Keywords: Entecavir; Genetic factors; Hepatocellular carcinoma; Interferon.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Professor Norifumi Kawada has received grants from Bristol-Myers K.K. and Chugai Pharmaceutical Co., Ltd.

Figures

Figure 1
Figure 1
The mechanisms of activation of hepatic stellate cells during chronic liver injury, resulting in synthesis of excess extracellular matrix. Once chronic liver injury has occurred, damaged hepatocytes, activated sinusoidal cells, platelets, and recruited inflammatory cells release various profibrogenic cytokines, which activate hepatic stellate cells, resulting in synthesis of excess extracellular matrix, such as type I and type III collagens. ECM: Extracellular matrix; IL: Interleukin; PDGF: Platelet-derived growth factor; TGF-β: Transforming growth factor-β; TNF-α: Tumor necrosis factor-α.

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. - PubMed
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. - PMC - PubMed
    1. World Health Organization. Hepatitis B [Fact sheet]. Updated July 2015. Accessed October 11, 2016. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/
    1. Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives. Liver Int. 2016;36 Suppl 1:47–57. - PubMed
    1. Tamori A, Enomoto M, Kawada N. Recent Advances in Antiviral Therapy for Chronic Hepatitis C. Mediators Inflamm. 2016;2016:6841628. - PMC - PubMed

Substances